Literature DB >> 31837315

Outcome of Descemet Membrane Endothelial Keratoplasty Using Corneas from Donors ≥80 Years of Age.

Friederike Schaub1, Maurice Collmer2, Silvia Schrittenlocher2, Björn O Bachmann2, Claus Cursiefen3, Deniz Hos3.   

Abstract

PURPOSE: The purpose of this study was to investigate whether corneas from donors ≥80 years old are suitable for Descemet membrane endothelial keratoplasty (DMEK).
DESIGN: Retrospective, comparative, interventional case series.
METHODS: Records of 1,765 consecutive DMEKs were reviewed and matched with corresponding donor tissue data. Older donors (≥80 years of age) were compared to younger donors (<80 years). Outcome measurements in DMEK recipients included best spectacle-corrected visual acuity (BSCVA), endothelial cell density (ECD), central corneal thickness (CCT) at 3 and 6 months and at 1, 2, and 3 years' follow-up and re-bubbling rates.
RESULTS: Of 1,748 DMEKs, 284 (16.2%) were performed with older donor lamellae (mean donor age, 83.96 ± 3.19 years; range, 80-94 years) and 1,464 (83.7%) with younger donor tissue (mean donor age, 65.27 ± 9.57 years; range, 17-79). BSCVA results were comparable for all postoperative time points. CCT results for younger donors were more favorable in the early postoperative course (P < 0.001 at 6 months; and P < 0.001 at 1 year), whereas mid-term results were comparable in both groups. ECD values were significantly higher in donors <80 years of age preoperatively and during the first 2 postoperative years (P ≤ 0.024). Overall re-bubbling rates were comparable in both groups.
CONCLUSIONS: Older donors, ≥80 to 94 years of age, seem to produce comparable mid-term functional results following DMEK surgery compared to younger donors. The use of corneas from donors aged ≥80 for DMEK surgery may therefore be a promising approach to counteract global donor shortage.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31837315     DOI: 10.1016/j.ajo.2019.12.001

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Clinical results after single asymmetrical shark fin for graft orientation in DMEK.

Authors:  Annekatrin Rickmann; Karl Boden; André M Trouvain; Lisa J Müller; Catheline Bocqué; Sebastian Thaler; Peter Szurman
Journal:  Int Ophthalmol       Date:  2021-10-31       Impact factor: 2.031

2.  Outcomes of Descemet Membrane Endothelial Keratoplasty in Bangkok, Thailand.

Authors:  Kaevalin Lekhanont; Punyanuch Pisitpayat; Nontawat Cheewaruangroj; Passara Jongkhajornpong; Manachai Nonpassopon; Thunyarat Anothaisintawee
Journal:  Clin Ophthalmol       Date:  2021-05-31

3.  Utilization rate and usage patterns of phakic and pseudophakic donor corneas recovered by the Singapore Eye Bank.

Authors:  Sai Kyauk; Howard Y Cajucom-Uy; Hla Myint Htoon; Z Zaw Htoi Aung; Jodhbir S Mehta; Arundhati Anshu
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

Review 4.  The Cologne-Mecklenburg-Vorpommern DMEK Donor Study (COMEDOS) - design and review of the influence of donor characteristics on Descemet membrane endothelial keratoplasty (DMEK) outcome.

Authors:  Silvia Schrittenlocher; Mario Matthaei; Björn Bachmann; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.